《Frontiers Of Medicine》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱醫(yī)學(xué)前沿,本刊主要出版、報道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.9,最新CiteScore 指數(shù)為18.3。
本刊近期中國學(xué)者發(fā)表的論文主要有:
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
Frontiers of Medicine is an international general medical journal sponsored by the Ministry of Education of China. The journal is jointly published by the Higher Education Press and Springer. Online versions are available through http://link.springer.com/. Since the first issue of 2010, this journal has been indexed in PubMed/MEDLINE.
Frontiers of Medicine is dedicated to publishing original research and review articles on the latest advances in clinical and basic medicine with a focus on epidemiology, traditional Chinese medicine, translational research, healthcare, public health and health policies. The journal employs a rigorous peer-review and editing process to ensure the scientific accuracy, novelty and importance of the manuscripts. Frontiers of Medicine is committed to promoting health and health care through communications among professionals in medical care, disease prevention and scientific research throughout the world by updating the progress in medicine, sharing experiences in disease control and treatment and exchanging views on health policies, medical services and health care reform.
中科院SCI分區(qū)
Frontiers Of Medicine雜志中科院分區(qū)信息
2023年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 3區(qū)
ONCOLOGY 腫瘤學(xué) 4區(qū)
2022年12月升級版
綜述:否
TOP期刊:是
大類:醫(yī)學(xué) 1區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 2區(qū)
ONCOLOGY 腫瘤學(xué) 2區(qū)
2021年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 3區(qū)
ONCOLOGY 腫瘤學(xué) 3區(qū)
2021年12月基礎(chǔ)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 3區(qū)
ONCOLOGY 腫瘤學(xué) 3區(qū)
2021年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 3區(qū)
ONCOLOGY 腫瘤學(xué) 3區(qū)
2020年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實驗 3區(qū)
該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在MEDICINE, RESEARCH & EXPERIMENTAL綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。